These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 12894990)

  • 1. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss).
    Shapiro J; Kaufman KD
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):20-3. PubMed ID: 12894990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Finasteride in the treatment of alopecia.
    Libecco JF; Bergfeld WF
    Expert Opin Pharmacother; 2004 Apr; 5(4):933-40. PubMed ID: 15102575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
    Whiting DA
    Eur J Dermatol; 2001; 11(4):332-4. PubMed ID: 11399540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L; Hordinsky M; Fiedler V; Swinehart J; Unger WP; Cotterill PC; Thiboutot DM; Lowe N; Jacobson C; Whiting D; Stieglitz S; Kraus SJ; Griffin EI; Weiss D; Carrington P; Gencheff C; Cole GW; Pariser DM; Epstein ES; Tanaka W; Dallob A; Vandormael K; Geissler L; Waldstreicher J
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily.
    Price VH; Menefee E; Sanchez M; Ruane P; Kaufman KD
    J Am Acad Dermatol; 2002 Apr; 46(4):517-23. PubMed ID: 11907500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finasteride in the treatment of Japanese men with male pattern hair loss.
    Kawashima M; Hayashi N; Igarashi A; Kitahara H; Maeguchi M; Mizuno A; Murata Y; Nogita T; Toda K; Tsuboi R; Ueki R; Yamada M; Yamazaki M; Matsuda T; Natsumeda Y; Takahashi K; Harada S
    Eur J Dermatol; 2004; 14(4):247-54. PubMed ID: 15319158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
    Roberts JL; Fiedler V; Imperato-McGinley J; Whiting D; Olsen E; Shupack J; Stough D; DeVillez R; Rietschel R; Savin R; Bergfeld W; Swinehart J; Funicella T; Hordinsky M; Lowe N; Katz I; Lucky A; Drake L; Price VH; Weiss D; Whitmore E; Millikan L; Muller S; Gencheff C
    J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia.
    Kaufman KD; Dawber RP
    Expert Opin Investig Drugs; 1999 Apr; 8(4):403-15. PubMed ID: 15992088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH; Menefee E; Sanchez M; Kaufman KD
    J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dutasteride in Androgenetic Alopecia: An Update.
    Arif T; Dorjay K; Adil M; Sami M
    Curr Clin Pharmacol; 2017; 12(1):31-35. PubMed ID: 28294070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
    Kaufman KD; Rotonda J; Shah AK; Meehan AG
    Eur J Dermatol; 2008; 18(4):400-6. PubMed ID: 18573712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5 alpha-reductase and finasteride in pattern alopecia and acne.
    Burkhart CG; Burkhart CN
    J Drugs Dermatol; 2004; 3(4):363-4. PubMed ID: 15303779
    [No Abstract]   [Full Text] [Related]  

  • 14. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group.
    Kaufman KD; Olsen EA; Whiting D; Savin R; DeVillez R; Bergfeld W; Price VH; Van Neste D; Roberts JL; Hordinsky M; Shapiro J; Binkowitz B; Gormley GJ
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):578-89. PubMed ID: 9777765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia.
    Finasteride Male Pattern Hair Loss Study Group
    Eur J Dermatol; 2002; 12(1):38-49. PubMed ID: 11809594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride: a review of its use in male pattern hair loss.
    McClellan KJ; Markham A
    Drugs; 1999 Jan; 57(1):111-26. PubMed ID: 9951956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
    Lin JH; Chen WC
    Kaohsiung J Med Sci; 2002 Aug; 18(8):379-85. PubMed ID: 12476680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM; García-Hernández MJ; Fernández-Crehuet JL
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgenetic alopecia and current methods of treatment.
    Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A; Takeda A
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.